Topics

China YCT International Group Inc. Company Profile

23:39 EST 12th December 2019 | BioPortfolio

Established in 2005, China YCT International Group Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong Spring Pharmaceutical"), a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare products, ginkgo cosmetics, daily-use chemical products, ginkgo glycoside products and biological medicines. All of Shandong YCT's businesses are currently in China.


News Articles [2231 Associated News Articles listed on BioPortfolio]

Loneliness heightened among gay men in certain age group in China

(University of Hawaii at Manoa) Gay men in China ages 25-29 are eight times more likely to feel criticized and rejected compared with men in that country ages 20 or younger, new research shows. The st...

AstraZeneca invests $1 billion in China

The British drugmaker is launching a fund with China International Capital Corporation and will also begin distributing Sun Pharma cancer drugs in China

AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

Shenzhen, China, Oct. 25, 2019 (GLOBE NEWSWIRE) Read more...

Aesthetic Medical International Holdings Group Limited Reports Third Quarter 2019 Unaudited ...

Shenzhen, China, Nov. 26, 2019 (GLOBE NEWSWIRE) Read more...

Merck KGaA Backs Startups in China

German pharmaceuticals, chemicals and life science group Merck has launched a €13 million seed fund to support start-ups in China. At the opening of its Innovation Hub Shanghai, Merck simultaneou...

MEBO Group exhibits new products on CIIE again to promote the internationalization of traditional Chinese medicines (TCMS)

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- The 2nd China International Import Expo (CIIE) is held in Shanghai, China, from November 5 to November 10, 2019. MEBO International, the US company of MEBO Group...

'Buy China' In Procurement Schemes - Should You Worry?

A recent trade group report points to a rising and alarming "Buy China" trend in procurement rounds in the country...    

Temasek, Hillhouse Pay $259 Million for 2% Stake in China's Aier Eye Hospital

Temasek, Singapore's sovereign wealth fund, and Beijing's Hillhouse Capital Group will acquire a 2% stake in Aier Eye Hospital Group for $259 million. The shares will be sold by Aier Medical Investmen...

PubMed Articles [4024 Associated PubMed Articles listed on BioPortfolio]

Epidemiological Characteristics and Spatiotemporal Patterns of Typhus Group Rickettsiosis at the County Level in China, 2005-2017.

To explore the epidemiological characteristics and spatiotemporal patterns of typhus group rickettsiosis (TGR) in mainland China.

Mapping of Health Technology Assessment in China: Situation Analysis and International Comparison.

To analyze the current development of HTA in China and to identify areas for improvement, we mapped the level of HTA development in China and compared it with the level of HTA development in ten other...

The 2nd International Symposium on Biofilms, 11-13 October 2019, South China University of Technology, China.

Risk assessment and genomic characterization of Zika virus in China and its surrounding areas.

Zika virus (ZIKV) has emerged as a global pathogen causing significant public health concerns. China has reported several imported cases where ZIKV were carried by travelers who frequently travel betw...

Prevalence of Cryptosporidium in dairy cattle in China during 2008-2018: A systematic review and meta-analysis.

Cryptosporidium is the causative agent of cryptosporidiosis. Cryptosporidium not only has a worldwide distribution, but also can infect various hosts, including dairy cattle and humans. Although numer...

Clinical Trials [7605 Associated Clinical Trials listed on BioPortfolio]

Baseline Investigation of Patients With Cardiac Arrest in China

BASIC is a perspective, multicentre and large-scale registry focusing on of patients suffering a cardiac arrest in China. The aims of the study are to establish the monitoring sites coveri...

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

This clinical trial is an international, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial comparing one dose of linaclotide to placebo. Approximately 800 pat...

Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China

Data on neonatal GBS disease are very limited in China. Acceptance and implementation of prevention measures such as antibiotics prevention or vaccination against GBS disease would require...

International Programs Collaborative Studies Coordinating Center

To continue the work of the Collaborative Studies Coordinating Center (CSCC) on international studies in cardiopulmonary disease epidemiology. The work was being performed under bilateral...

Multi-center Study on Children's and Adolescents' Medulloblastoma Molecular Subgroups in China

Recently, diagnosis and treatments for medulloblastoma becomes more complicated than before since the new World Health Organization (WHO) diagnosis criteria has put molecular marker onto a...

Companies [3702 Associated Companies listed on BioPortfolio]

China YCT International Group, Inc.

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic...

China YCT International Group Inc.

Established in 2005, China YCT International Group Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong Spring Pharmaceutical"), a corporation organized under...

China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ("Yingxia"), is primarily engaged in the development, production and sales of health...

eChinaChem

eChinaChem, Inc., the China subsidiary of Pacific Genuity, Inc. (San Carlos, California), provides an integrated end-to-end solution for international chemical trading with China. Our company offers ...

China Kangtai Cactus Bio-tech Inc.

China Kangtai Cactus Bio-tech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy...

More Information about "China YCT International Group Inc." on BioPortfolio

We have published hundreds of China YCT International Group Inc. news stories on BioPortfolio along with dozens of China YCT International Group Inc. Clinical Trials and PubMed Articles about China YCT International Group Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China YCT International Group Inc. Companies in our database. You can also find out about relevant China YCT International Group Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record